Stock Information
  Financial News
  Earnings Estimate
  Media Kit
  Analyst Coverage
  Corporate Presentation
  Financial Reports
  SEC Filings
  Event Calendar
  FAQs
  E-mail Alerts
  Information Request


The Company currently has several late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas.



DURECT Corporation is a specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas.

... 
More >>
Featured Report
Download Documentation DURECT 2013 Letter to the Shareholders
DRRX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$1.88
Change (%) Stock is Up 0.13 (7.43%)
Volume2,024,073
Data as of 03/27/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
03/02/15DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of ProgramsPrinter Friendly Version
03/02/15DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in DevelopmentPrinter Friendly Version
02/23/15DURECT Corporation Invites You to Join its Fourth Quarter 2014 Earnings Conference CallPrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever DURECT Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 
Transfer Agent
Computershare Trust Company N.A.
250 Royall Street, Mailstop 3B
Canton, MA 02021
Phone: 781- 575-3400

Accountants
Ernst & Young LLP
1001 Page Mill Road
Palo Alto, CA 94304
Phone: 650-496-1600
Fax: 650-496-1600

Data provided by Nasdaq. Minimum 15 minutes delayed.




© 2000-2012 DURECT Corporation
Last updated: September 20, 2011
Search    Contact    Site Index    Legal Notice    Privacy Policy